Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit
Molecules · 20.02.2023 · 28 (4) · 1982
DOI: 10.3390/molecules28041982 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 20.02.2023. Verfasst von Behrouz Mollashahi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The most widely used genome editing toolkit is CRISPR (clustered regularly interspaced short palindromic repeats). It provides the possibility of replacing and modifying DNA and RNA nucleotides. Furthermore, with advancements in biological technology, inhibition and activation of the transcription of specific gene(s) has become possible. Bioinformatics tools that target the evolution of CRISPR-associated protein 9 (Cas9) turn this protein into a vehicle that is specific for a DNA or RNA region with single guide RNA (sgRNA). This toolkit could be used by researchers to investigate the function of stem cell gene(s). Here, in this review article, we cover recent developments and applications of this technique in stem cells for research and clinical purposes and discuss different CRISPR/Cas technologies for knock-out, knock-in, activation, or inhibition of gene expression. Additionally, a comparison of several deliveries and off-target detecting strategies is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, 40126 Bologna, Italy.
- Department of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology, Tehran 14965/161, Iran.
- Department of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamedan 6517838636, Iran.
- INSERM UMR-S-MD 1197, Hôpital Paul Brousse, Paris-Saclay University, 94807 Villejuif, France.
- CellMedEx, 94100 Saint Maur Des Fossés, France.
ORCID-Profile: Behrouz Mollashahi, Iman Owliaee, Saleh Jamehdor, Sina Naserian
Zitieren
APA
Mollashahi, B., Latifi-Navid, H., Owliaee, I., Shamdani, S., Uzan, G., Jamehdor, S., & Naserian, S. (2023). Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit. Molecules, 28(4), 1982. https://doi.org/10.3390/molecules28041982
Vancouver
Mollashahi B, Latifi-Navid H, Owliaee I, Shamdani S, Uzan G, Jamehdor S, et al. Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit. Molecules. 2023;28(4):1982. doi:10.3390/molecules28041982
BibTeX
@article{Mollashahi2023,
author = {Mollashahi, Behrouz and Latifi-Navid, Hamid and Owliaee, Iman and Shamdani, Sara and Uzan, Georges and Jamehdor, Saleh and Naserian, Sina},
title = {Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit},
journal = {Molecules},
year = {2023},
volume = {28},
number = {4},
pages = {1982},
doi = {10.3390/molecules28041982}
}
EUVIMED